Computational Simulations Identify Pyrrolidine-2,3-Dione Derivatives as Novel Inhibitors of Cdk5/p25 Complex to Attenuate Alzheimer’s Pathology

Published on May 24, 2019in Journal of Clinical Medicine5.688
· DOI :10.3390/jcm8050746
Amir Zeb5
Estimated H-index: 5
Donghwan Kim1
Estimated H-index: 1
+ 9 AuthorsKeun Woo Lee30
Estimated H-index: 30
Mechanistically, neurotoxic insults provoke Ca2+-mediated calpain activation, which cleaves the cytoplasmic region of membrane-embedded p35 and produces its truncated form p25. Upon physical interaction, cyclin-dependent kinase 5 (Cdk5) and p25 forms hyperactivated Cdk5/p25 complex and causes severe neuropathological aberrations including hyperphosphorylated tau-mediated neurofibrillary tangles formation, Alzheimer’s symptoms, and neuronal death. Therefore, the inhibition of Cdk5/p25 complex may relieve p-tau-mediated Alzheimer’s pathology. Herein, computational simulations have identified pyrrolidine-2,3-dione derivatives as novel inhibitors of Cdk5/p25 complex. A ligand-based pharmacophore was designed and employed as 3D query to retrieve drug-like molecules from chemical databases. By molecular docking, drug-like molecules obtaining dock score > 67.67 (Goldcore of the reference compound) were identified. Molecular dynamics simulation and binding free energy calculation retrieved four pyrrolidine-2,3-dione derivatives as novel candidate inhibitors of Cdk5/p25. The root means square deviation of Cdk5/p25 in complex with candidate inhibitors obtained an average value of ~2.15 A during the 30 ns simulation period. Molecular interactions analysis suggested that each inhibitor occupied the ATP-binding site of Cdk5/p25 and formed stable interactions. Finally, the binding free energy estimation suggested that each inhibitor had lowest binding energy than the reference compound (−113.10 kJ/mol) to recapitulate their strong binding with Cdk5/p25. Overall, these inhibitors could mitigate tau-mediated Alzheimer’s phenotype.
  • References (66)
  • Citations (0)
📖 Papers frequently viewed together
10 Authors (P Hazel, ..., Paul S. Freemont)
6 Citations
2 Citations
24 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
#1Amir Zeb (Gyeongsang National University)H-Index: 5
#2Chanin Park (Gyeongsang National University)H-Index: 8
Last. Keun Woo Lee (Gyeongsang National University)H-Index: 30
view all 11 authors...
Abstract Photodynamic therapy (PDT) is a rapidly evolving area of cancer management against solid tumors. PDT is either administrated by injecting photosensitizer (porphyrins) or by accumulation of intracellular protoporphyrin IX via the inhibition of human Protoporphyrinogen Oxidase IX (hPPO). In this study, novel inhibitors of hPPO have been investigated by integrating virtual screening, molecular docking, and molecular dynamics (MD) simulation. A ligand-based pharmacophore was generated from ...
1 CitationsSource
#1Amir Zeb (Gyeongsang National University)H-Index: 5
#2Chanin Park (Gyeongsang National University)H-Index: 8
Last. Keun Woo Lee (Gyeongsang National University)H-Index: 30
view all 6 authors...
Protein acetylation and deacetylation play vital roles in the structural and physiological behavior of target proteins. Histone deacetylase 6 (HDAC6) remains a key therapeutic target in several chronic diseases such as cancer, neurodegenerative, and hematological diseases. In tau-pathogenesis, HDAC6 tightly regulates microtubule-associated tau physiology, and its inhibition suppresses Alzheimer’s phenotype. To this end, the current study has identified novel HDAC6 inhibitors by structure-based d...
3 CitationsSource
#1Chirag N. Patel (Gujarat University)H-Index: 5
#2John J. Georrge (Christ College Rajkot)H-Index: 2
Last. Himanshu A. Pandya (Gujarat University)H-Index: 9
view all 7 authors...
Alzheimer’s disease (AD) is one of the most significant neurodegenerative disorders and its symptoms mostly appear in aged people. Catechol-o-methyltransferase (COMT) is one of the known target enz...
10 CitationsSource
#1Shailima Rampogu (Gyeongsang National University)H-Index: 7
#2Ayoung Baek (Gyeongsang National University)H-Index: 7
Last. Keun Woo Lee (Gyeongsang National University)H-Index: 30
view all 4 authors...
Angiogenesis is a process of formation of new blood vessels and is an important criteria demonstrated by cancer cells. Over a period of time, these cancer cells infect the other parts of the healthy body by a process called progression. The objective of the present article is to identify a drug molecule that inhibits angiogenesis and progression. In this pursuit, ligand based pharmacophore virtual screening was employed, generating a pharmacophore model, Hypo1 consisting of four features. Furthe...
12 CitationsSource
#1Sara Guariento (UniGe: University of Genoa)H-Index: 6
#2Michele Tonelli (UniGe: University of Genoa)H-Index: 8
Last. Elena Cichero (UniGe: University of Genoa)H-Index: 16
view all 6 authors...
Abstract The design of novel chemical classes acting towards several G-protein-coupled receptors (GPCRs) represents a leading strategy in drug discovery, aimed at deriving effective and safe candidates for further assessment. During the last years, TAAR1 arose as a promising druggable target in medicinal chemistry, being of interest in the treatment of several pathologies, such as neuropsychiatric disorders, type 2 diabetes and obesity. Nevertheless, the limited number of known potent and select...
4 CitationsSource
#1Ting-Ting Yao (ZJU: Zhejiang University)H-Index: 4
#2Jiang-Feng Xie (ZJU: Zhejiang University)H-Index: 2
Last. Xiaowu Dong (ZJU: Zhejiang University)H-Index: 16
view all 7 authors...
An integrated virtual screening protocol by combining molecular docking and pharmacophore mapping was established to identify novel inhibitors of JAK2 from a commercial compound database. Twelve novel and structurally diverse hits were selected and subjected to in vitro biological tests, and three compounds (A5, A6 and A9) with remarkable JAK2 inhibitory activity were identified. Then, the obtained structures were further used as the template for a subsequent similarity search, leading to the id...
8 CitationsSource
Abstract Recently, 1-(1,4-dioxaspiro[4,5]dec-2-ylmethyl)-4-(2-methoxyphenyl)piperazine ( 1 ) was reported as a potent 5-HT 1A R agonist with a moderate 5-HT 1A R selectivity. In an extension of this work a series of derivatives of 1, obtained by combining different heterocyclic rings with a more flexible amine chain, was synthesized and tested for binding affinity and activity at 5-HT 1A R and α 1 adrenoceptors. The results led to the identification of 14 and 15 as novel 5-HT 1A R partial agonis...
17 CitationsSource
#1Jing Huang (UMB: University of Maryland, Baltimore)H-Index: 13
#2Sarah Rauscher (MPG: Max Planck Society)H-Index: 12
Last. Alexander D. MacKerell (UMB: University of Maryland, Baltimore)H-Index: 70
view all 8 authors...
An all-atom protein force field, CHARMM36m, offers improved accuracy for simulating intrinsically disordered peptides and proteins.
350 CitationsSource
#1Sneha Patil (AIMS: Amrita Institute of Medical Sciences and Research Centre)H-Index: 1
#2Ankit TyagiH-Index: 1
Last. C. Gopi Mohan (AIMS: Amrita Institute of Medical Sciences and Research Centre)H-Index: 15
view all 5 authors...
Alzheimer’s disease is a progressive neurodegenerative disorder arising due to genetic and non-genetic causes. One of the major therapies adapted for symptomatic Alzheimer’s disease is by targeting acetylcholinesterase enzyme based on the cholinergic hypothesis. Acetylcholinesterase is a substrate-specific enzyme that degrades the neuro-transmitter acetylcholine. An optimum level of acetylcholine should be maintained in the brain for its proper function. In order to identify potent and selective...
3 CitationsSource
#1Philippe Bergeron (Genentech)H-Index: 12
#2Michael F. T. Koehler (Genentech)H-Index: 17
Last. Maureen Beresini (Genentech)H-Index: 19
view all 16 authors...
Using Sorafenib as a starting point, a series of potent and selective inhibitors of CDK8 was developed. When cocrystallized with CDK8 and cyclin C, these compounds exhibit a Type-II (DMG-out) binding mode.
18 CitationsSource
Cited By0